Trexquant Investment’s Acceleron Pharma XLRN Stock Holding History

Trexquant Investment’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,616	Closed	-$454K	–	1634
2021 Q2	$454K	Buy	+3,616	New	+$456K	0.04%	537
2020 Q3	–	Sell	-11,716	Closed	-$1.12M	–	1649
2020 Q2	$1.12M	Buy	11,716 +7,575	+183%	+$730K	0.08%	363
2020 Q1	$372K	Buy	+4,141	New	+$322K	0.03%	770
2018 Q2	–	Sell	-8,292	Closed	-$324K	–	1352
2018 Q1	$324K	Buy	+8,292	New	+$352K	0.02%	786
2017 Q4	–	Sell	-7,120	Closed	-$266K	–	1318
2017 Q3	$266K	Buy	+7,120	New	+$247K	0.07%	511
2017 Q2	–	Sell	-10,601	Closed	-$281K	–	1299
2017 Q1	$281K	Buy	+10,601	New	+$279K	0.04%	788
2015 Q3	–	Sell	-16,295	Closed	-$515K	–	1343
2015 Q2	$515K	Buy	+16,295	New	+$526K	0.06%	609

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Trexquant Investment's XLRN Position: Q3 2021 in Review

Trexquant Investment sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 3,616 shares — an estimated $454K sold.

Trexquant Investment first reported a position in XLRN in Q2 2015 and held it in 7 quarters. The position peaked at $1.12M in Q2 2020. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

Trexquant Investment reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
Trexquant Investment sold 3,616 Acceleron Pharma shares in Q3 2021, an estimated $454K.
Trexquant Investment first reported a position in Acceleron Pharma in Q2 2015 and held it in 7 quarters.
Trexquant Investment's Acceleron Pharma position peaked at $1.12M in Q2 2020.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.